SONOMA PHARMACEUTICALS INC (SNOA) Stock Balance Sheet
NASDAQ:SNOA • US83558L3033
Current stock price
2.3 USD
+0.09 (+4.07%)
At close:
2.1 USD
-0.2 (-8.7%)
After Hours:
| MRQ (2025-12-31) | 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 2.56M | 5.37M | 3.13M | 3.82M | 7.40M | |||
| Receivables | 2.38M | 3.76M | 5.99M | 6.42M | 4.78M | |||
| Inventories | 3.70M | 2.92M | 2.72M | 2.86M | 2.66M | |||
| Other Current Assets | 3.50M | 596.00K | 707.00K | 700.00K | 1.60M | |||
| Total Current Assets | 12.14M | 12.65M | 12.55M | 13.80M | 16.43M | |||
| Non-Current Assets | ||||||||
| PPE Net | 956.00K | 309.00K | 651.00K | 910.00K | 880.00K | |||
| Other Non-Current Assets | 522.00K | 736.00K | 1.54M | 1.53M | 1.54M | |||
| Total Non-Current Assets | 1.48M | 1.04M | 2.19M | 2.43M | 2.42M | |||
| TOTAL ASSETS | 13.62M | 13.69M | 14.74M | 16.23M | 18.85M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 220.00K | 323.00K | 430.00K | 690.00K | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 120.00K | |||
| Accrued Expenses | 2.26M | 1.79M | 1.62M | 1.72M | 1.31M | |||
| Accounts Payable | 1.65M | 953.00K | 607.00K | 840.00K | 1.64M | |||
| Other Current Liabilities | 314.00K | 1.13M | 1.17M | 730.00K | 2.06M | |||
| Total Current Liabilities | 4.22M | 4.10M | 3.72M | 3.72M | 5.82M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 5.97M | 5.19M | 4.88M | 4.54M | 4.33M | |||
| Total Non-Current Liabilities | 5.97M | 5.19M | 4.88M | 4.53M | 4.33M | |||
| TOTAL LIABILITIES | 10.19M | 9.28M | 8.60M | 8.25M | 10.15M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -200.40M | -197.81M | -194.35M | -189.51M | -184.36M | |||
| Additional Paid In Capital | 207.02M | 206.59M | 203.21M | 200.90M | 197.37M | |||
| Common Shares | 200.00 | 200.00 | 2.00K | 10.00K | 0.00 | |||
| Other Shareholders' Equity | -3.19M | -4.38M | -2.72M | -3.42M | -4.31M | |||
| Shares Outstanding | 1.73M | 1.63M | 780.40K | 4.93M | 3.10M | |||
| Tangible Book Value per Share | 1.98 | 2.70 | 7.86 | 1.62 | 2.81 | |||
| Total Shareholders' Equity | 3.43M | 4.41M | 6.14M | 7.98M | 8.70M | |||
| TOTAL LIABILITIES AND EQUITY | 13.62M | 13.69M | 14.74M | 16.23M | 18.85M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 2.88 | 3.09 | 3.37 | 3.71 | 2.82 | |||
| Return On Assets (ROA) | -24.74% | -25.25% | -32.80% | -31.73% | -27.00% | |||
| Return On Equity (ROE) | -98.19% | -78.37% | -78.78% | -64.54% | -58.51% | |||
All data in USD , ROIC based on taxRate of 0.21